deltatrials
Terminated NA INTERVENTIONAL 3-arm NCT02179359

Hematopoietic Stem Cell Transplant for High Risk Hemoglobinopathies

MT2014-10C: Allogeneic Hematopoietic Stem Cell Transplant for Patients With High Risk Hemoglobinopathies and Other Red Cell Transfusion Dependent Disorders

Sponsor: Masonic Cancer Center, University of Minnesota

Conditions Diamond Blackfan Anemia Glanzmann Thrombasthenia Non-Malignant Hematologic Disorders Paroxysmal Nocturnal Hemoglobinuria Severe Congenital Neutropenia Shwachman-Diamond Syndrome Sickle Cell Disease Transfusion Dependent Alpha- or Beta- Thalassemia
Interventions Myeloablative Preparative Regimen Reduced Intensity Preparative Regimen Reduced Toxicity Ablative Regimen
Updated 16 times since 2017 Last updated: Feb 27, 2025 Started: Sep 2, 2014 Primary completion: Nov 21, 2024 Completion: Nov 21, 2024
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Replaced by another study

Other terminated trials from Masonic Cancer Center, University of Minnesota

See all terminations from Masonic Cancer Center, University of Minnesota

Other Diamond Blackfan Anemia trials with similar outcome

Browse all Diamond Blackfan Anemia trials

This NA trial investigates Diamond Blackfan Anemia and Glanzmann Thrombasthenia and is currently terminated or withdrawn. Masonic Cancer Center, University of Minnesota leads this study, which shows 16 recorded versions since 2014 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshot~Feb 2017 – ~May 2017 · 3 months · monthly snapshot~May 2017 – ~Jun 2018 · 13 months · monthly snapshot~Jun 2018 – ~Oct 2018 · 4 months · monthly snapshot~Oct 2018 – ~Oct 2019 · 12 months · monthly snapshot~Oct 2019 – ~Oct 2020 · 12 months · monthly snapshot~Oct 2020 – ~Jan 2021 · 3 months · monthly snapshot~Jan 2021 – ~Jun 2021 · 5 months · monthly snapshot~Jun 2021 – ~Oct 2021 · 4 months · monthly snapshot~Oct 2021 – ~May 2022 · 7 months · monthly snapshot~May 2022 – ~May 2023 · 12 months · monthly snapshot~May 2023 – ~Mar 2024 · 10 months · monthly snapshot~Mar 2024 – ~Jul 2024 · 4 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Apr 2025 · 7 months · monthly snapshot~Apr 2025 – present · 15 months · monthly snapshot

Change History

16 versions recorded

  1. Apr 2025 — Present [monthly]

    Terminated NA

    Status: Recruiting → Terminated

  2. Sep 2024 — Apr 2025 [monthly]

    Recruiting NA

  3. Jul 2024 — Sep 2024 [monthly]

    Recruiting NA

  4. Mar 2024 — Jul 2024 [monthly]

    Recruiting NA

  5. May 2023 — Mar 2024 [monthly]

    Recruiting NA

▶ Show 11 earlier versions

  1. May 2022 — May 2023 [monthly]

    Recruiting NA

  2. Oct 2021 — May 2022 [monthly]

    Recruiting NA

  3. Jun 2021 — Oct 2021 [monthly]

    Recruiting NA

  4. Jan 2021 — Jun 2021 [monthly]

    Recruiting NA

  5. Oct 2020 — Jan 2021 [monthly]

    Recruiting NA

  6. Oct 2019 — Oct 2020 [monthly]

    Recruiting NA

  7. Oct 2018 — Oct 2019 [monthly]

    Recruiting NA

  8. Jun 2018 — Oct 2018 [monthly]

    Recruiting NA

  9. May 2017 — Jun 2018 [monthly]

    Recruiting NA

  10. Feb 2017 — May 2017 [monthly]

    Recruiting NA

  11. Jan 2017 — Feb 2017 [monthly]

    Recruiting NA

    First recorded

Sep 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Masonic Cancer Center, University of Minnesota
Data source: Masonic Cancer Center, University of Minnesota

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations